Literature DB >> 17082614

Oligomerization of CXCL10 is necessary for endothelial cell presentation and in vivo activity.

Gabriele S V Campanella1, Jan Grimm, Lindsay A Manice, Richard A Colvin, Benjamin D Medoff, Gregory R Wojtkiewicz, Ralph Weissleder, Andrew D Luster.   

Abstract

The chemokine IFN-gamma-inducible protein of 10 kDa (IP-10; CXCL10) plays an important role in the recruitment of activated T lymphocytes into sites of inflammation by interacting with the G protein-coupled receptor CXCR3. IP-10, like other chemokines, forms oligomers, the role of which has not yet been explored. In this study, we used a monomeric IP-10 mutant to elucidate the functional significance of oligomerization. Although monomeric IP-10 had reduced binding affinity for CXCR3 and heparin, it was able to induce in vitro chemotaxis of activated T cells with the same efficacy as wild-type IP-10. However, monomeric IP-10 was unable to induce recruitment of activated CD8+ T cells into the airways of mice after intratracheal instillation. Use of a different IP-10 mutant demonstrated that this inability was due to lack of oligomerization rather than reduced CXCR3 or heparin binding. Molecular imaging demonstrated that both wild-type and monomeric IP-10 were retained in the lung after intratracheal instillation. However, in vitro binding assays indicated that wild-type, but not monomeric, IP-10 was retained on endothelial cells and could induce transendothelial chemotaxis of activated T cells. We therefore propose that oligomerization of IP-10 is required for presentation on endothelial cells and subsequent transendothelial migration, an essential step for lymphocyte recruitment in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082614     DOI: 10.4049/jimmunol.177.10.6991

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

Review 1.  Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring.

Authors:  Peter Adam Rees; Nicholas Stuart Greaves; Mohamed Baguneid; Ardeshir Bayat
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 2.  CXCR3 ligands: redundant, collaborative and antagonistic functions.

Authors:  Joanna R Groom; Andrew D Luster
Journal:  Immunol Cell Biol       Date:  2011-01-11       Impact factor: 5.126

Review 3.  Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function.

Authors:  C L Salanga; T M Handel
Journal:  Exp Cell Res       Date:  2011-01-09       Impact factor: 3.905

4.  Two glycosaminoglycan-binding domains of the mouse cytomegalovirus-encoded chemokine MCK-2 are critical for oligomerization of the full-length protein.

Authors:  Sergio M Pontejo; Philip M Murphy
Journal:  J Biol Chem       Date:  2017-04-21       Impact factor: 5.157

5.  The emerging role of CXCL10 in cancer (Review).

Authors:  Mingli Liu; Shanchun Guo; Jonathan K Stiles
Journal:  Oncol Lett       Date:  2011-05-09       Impact factor: 2.967

6.  Development of a novel chemokine-mediated in vivo T cell recruitment assay.

Authors:  Gabriele S V Campanella; Benjamin D Medoff; Lindsay A Manice; Richard A Colvin; Andrew D Luster
Journal:  J Immunol Methods       Date:  2008-01-09       Impact factor: 2.303

7.  Influenza H5N1 virus infection of polarized human alveolar epithelial cells and lung microvascular endothelial cells.

Authors:  Michael C W Chan; Renee W Y Chan; Wendy C L Yu; Carol C C Ho; W H Chui; C K Lo; Kit M Yuen; Y I Guan; John M Nicholls; J S Malik Peiris
Journal:  Respir Res       Date:  2009-10-30

8.  Structure of mouse IP-10, a chemokine.

Authors:  Talat Jabeen; Philip Leonard; Haryati Jamaluddin; K Ravi Acharya
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2008-05-14

9.  Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation.

Authors:  Gabriele Hoermannsperger; Gabriele Hörmannsperger; Thomas Clavel; Micha Hoffmann; Caroline Reiff; Denise Kelly; Gunnar Loh; Michael Blaut; Gabriele Hölzlwimmer; Melanie Laschinger; Dirk Haller
Journal:  PLoS One       Date:  2009-02-06       Impact factor: 3.240

10.  SufA of the opportunistic pathogen finegoldia magna modulates actions of the antibacterial chemokine MIG/CXCL9, promoting bacterial survival during epithelial inflammation.

Authors:  Christofer Karlsson; Mette Eliasson; Anders I Olin; Matthias Mörgelin; Anna Karlsson; Martin Malmsten; Arne Egesten; Inga-Maria Frick
Journal:  J Biol Chem       Date:  2009-07-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.